Skip to main content
. Author manuscript; available in PMC: 2011 Dec 2.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4138–4145. doi: 10.1167/iovs.05-1452

Figure 5.

Figure 5

Withanolide D targets the UPP in HUVECs and HCECs. HUVECs (A) and HCECs (B) were pretreated for 30 minutes with different concentrations of withanolide D (WD) and subsequently stimulated with 10 ng/mL TNF-α for 20 minutes. Cytoplasmic extracts were analyzed by Western blot with a monoclonal antibody against ubiquitin.